HPV mRNA E6/E7 indicates the presence of high risk HPV strains that can potentially lead to cancer. These strains instruct cells to produce proteins that may transform them into cancerous cells.

Human papillomavirus (HPV) is necessary for the development of cervical carcinoma, and incorporation of molecular testing for HPV in screening and patient management has been proposed. Sufficient ...

CD4, CD8 and PD1 immunoexpression in oral premalignant lesions (PML) and oral squamous cell carcinoma (OSCC) and its association with malignant transformation. This is an ASCO Meeting Abstract from ...

One of the main causes of cervical cancer is persistent human papillomavirus (HPV) infection, with E6 and E7 being the main oncogenic genes of HPV3. For this reason, targeting HPV proteins E6 and E7 ...

It is now common knowledge that some cancers are caused by viral infection. The explanation for this direct causal relationship differs between viruses. In the case of the human papilloma virus (HPV), ...

Human papillomavirus (HPV) infection as a prognostic factor in patients with oropharyngeal squamous cell carcinoma treated in a prospective phase II clinical trial No significant financial ...

Infection with HPV16, a high-risk human papillomavirus (HPV), can cause cervical cancer in humans. These infections carry a high risk of morbidity and mortality globally in females. This study aimed ...

Infection with high-risk strains of human papillomavirus (HPV) is one of the major risk factors for developing head and neck squamous cell carcinoma (HNSCC), a major cause of cancer deaths worldwide.

Enzo’s innovations are changing the story of HPV. The FLOWSCRIPT® Assay employs a novel, flow cytometry-based, in situ hybridization technique, utilizing a cocktail of probes specific to multiple ...

Since HPV cannot be cultured, HPV tests currently in use rely on the detection of viral nucleic acids in the infected tissue. [14] The most commonly used HPV tests are based on direct hybridization or ...